Trial Profile

A Phase 3B Open-Label Extension Of Study B23CS (ARENA 2) Evaluating The Continued Safety And Efficacy Of ADV7103 In Subjects With Primary Distal Renal Tubular Acidosis

Status: Withdrawn prior to enrolment

Phase of Trial: Phase III

Latest Information Update: 15 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Potassium bicarbonate/potassium citrate (Primary)
Indications Renal tubular acidosis
Focus Adverse reactions
Acronyms ARENA 2
Sponsors Advicenne

Most Recent Events

08 Mar 2024 Status changed from not yet recruiting to withdrawn prior to enrolment.
08 May 2023 Planned End Date changed from 30 Mar 2021 to 1 Mar 2025.
08 May 2023 Planned primary completion date changed from 30 Mar 2021 to 1 Jan 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com